Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell transplantation for post-ischemic heart failure.

J T Vilquin1, J P Marolleau, A Hagege

  • 1INSERM U 523-Institut de Myologie, Groupe hospitalier La-Pitié-La-Salpêtrière, 47, boulevard de l'Hôpital, 75651 Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 4, 2003
PubMed
Summary

Cell transplantation offers a promising strategy for treating post-ischemic heart failure. Skeletal muscle cell (SMC) transplantation has shown encouraging results in clinical trials, improving cardiac function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).

Revue neurologique·2024
Same author

Baseline [<sup>18</sup>F]FDG PET features are associated with survival and toxicity in patients treated with CAR T cells for large B cell lymphoma.

European journal of nuclear medicine and molecular imaging·2023
Same author

Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: A multicenter randomized controlled clinical trial.

Leukemia research·2023
Same author

Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study.

Annals of hematology·2023
Same author

CE-ICP-MS to probe Aβ1-42/copper (II) interactions, a complementary tool to study amyloid aggregation in Alzheimer's disease.

Metallomics : integrated biometal science·2021
Same author

Interactions between copper (II) and β-amyloid peptide using capillary electrophoresis-ICP-MS: Kd measurements at the nanogram scale.

Analytical and bioanalytical chemistry·2021

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Therapy

Background:

  • Post-ischemic heart failure presents a significant public health challenge with limited therapeutic options.
  • Cell transplantation is being explored as an alternative strategy to restore cardiac structure and function.

Purpose of the Study:

  • To review various cell types and clinical trials for cell transplantation in treating ischemic heart failure.
  • To assess the potential of different cell sources, including cardiomyocytes, endothelial progenitors, and skeletal muscle cells.

Main Methods:

  • Review of existing literature on cell types used in cardiac repair.
  • Analysis of clinical trial data for cell transplantation in ischemic heart failure.
  • Discussion of challenges and advancements in cell production and delivery.

Related Experiment Videos

Main Results:

  • Fetal/neonatal cardiomyocyte transplantation shows functional success but faces limitations.
  • Mesenchymal stem cells may yield autologous cardiomyocytes.
  • Endothelial progenitors from bone marrow can promote neoangiogenesis.
  • Skeletal muscle cell (SMC) transplantation improved myocardial function in animal models and early human trials.

Conclusions:

  • SMC transplantation has progressed to phase II clinical trials, showing encouraging results for severe ischemic heart failure.
  • Ongoing trials are evaluating bone marrow-derived cells for safety and efficacy.
  • Cellular therapies hold significant promise for managing ischemic heart failure.